Catalyst Pharmaceuticals (CPRX) EBT Growth (5y) (2015 - 2026)
Catalyst Pharmaceuticals (CPRX) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.51% |
| Dec 31, 2025 | 52.48% |
| Sep 30, 2025 | 43.35% |
| Jun 30, 2025 | 46.15% |
| Mar 31, 2025 | 45.22% |
| Dec 31, 2024 | 54.58% |
| Sep 30, 2024 | 32.07% |
| Jun 30, 2024 | 37.36% |
| Mar 31, 2024 | 116.11% |
| Dec 31, 2023 | 39.17% |
| Sep 30, 2023 | -37.14% |
| Jun 30, 2023 | 58.91% |
| Mar 31, 2023 | 53.59% |
| Dec 31, 2022 | 52.05% |
| Sep 30, 2022 | 52.42% |
| Jun 30, 2022 | 56.14% |
| Mar 31, 2022 | 40.70% |
| Dec 31, 2021 | 38.40% |
| Sep 30, 2021 | 40.93% |
| Jun 30, 2021 | 40.53% |